Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement.
Cell Discov
Date: Sep. 10, 2020
PubMed ID: 32901211
View in: Pubmed Google Scholar
Download Curated Data For This Publication
222219
Switch View:
- Interactions 2